Disclosures: The authors have disclosed that they have no financial interests, arrangements, or affiliations with the manufacturers of any products discussed in this article or their competitors.
Correspondence: Raed A. Dweik, MD, MBA, Innovation Management and Conflict of Interest Program, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195. Email: dweikr@ccf.org
ChimonasS, RozarioNM, RothmanDJ. Show us the money: lessons in transparency from state pharmaceutical marketing disclosure laws. Health Serv Res2010;45:98–114.
ChimonasS, RozarioNM, RothmanDJ. Show us the money: lessons in transparency from state pharmaceutical marketing disclosure laws. Health Serv Res 2010;45:98–114.19840133)| false
RoseSL, SanghaniRM, SchmidtC, et al.Gender differences in physicians’ financial ties to industry: a study of national disclosure data. PLoS One2015;10:e0129197.
RoseSL, SanghaniRM, SchmidtC, Gender differences in physicians’ financial ties to industry: a study of national disclosure data. PLoS One 2015;10:e0129197.26067810)| false
InoueK, BlumenthalDM, ElashoffD, et al.Association between physician characteristics and payments from industry in 2015–2017: observational study. BMJ Open2019;9:e031010.
InoueK, BlumenthalDM, ElashoffD, Association between physician characteristics and payments from industry in 2015–2017: observational study. BMJ Open 2019;9:e031010.31542759)| false
PerlisRH, PerlisCS. Physician payments from industry are associated with greater Medicare Part D prescribing costs. PLoS One 2016;11:e0155474.27183221)| false
KaestnerV, EdmistonJB, PrasadV. The relation between publication rate and financial conflict of interest among physician authors of high-impact oncology publications: an observational study. CMAJ Open2018;6:E57–62.
KaestnerV, EdmistonJB, PrasadV. The relation between publication rate and financial conflict of interest among physician authors of high-impact oncology publications: an observational study. CMAJ Open 2018;6:E57–62.29382668)| false
Fugh-BermanA, McDonaldCP, BellAM, et al.Promotional tone in reviews of menopausal hormone therapy after the Women’s Health Initiative: an analysis of published articles. PLoS Med2011;8:e1000425.
Fugh-BermanA, McDonaldCP, BellAM, Promotional tone in reviews of menopausal hormone therapy after the Women’s Health Initiative: an analysis of published articles. PLoS Med 2011;8:e1000425.21423581)| false
RahmanM, TrivediN, BachP, MitchellA. Increasing financial payments from industry to medical oncologists in the United States, 2014–2017 [published online December 28, 2021]. J Natl Compr Cancer Netw, doi: 10.6004/jnccn.2021.7024
RahmanM, TrivediN, BachP, MitchellA. Increasing financial payments from industry to medical oncologists in the United States, 2014–2017 [published online December 28, 2021]. J Natl Compr Cancer Netw, doi: 10.6004/jnccn.2021.7024)| false
TokarD. Health-care industry faces greater scrutiny around payments to doctors to promote products. Wall Street Journal. December 3, 2020. Accessed September 10, 2021. Available at: https://www.wsj.com/articles/health-care-industry-faces-greater-scrutiny-around-payments-to-doctors-to-promote-products-11606991402)| false